2024 Global Health Care Private Equity Deal Value Tops $115 Billion, Second-Highest Since 2019

Global health care private equity deal value during 2024 was estimated at $115 billion, representing the second highest annual deal value since 2019 according to data compiled by Bain & Company, a global management consulting firm. Deal value in 2023 was estimated at $61 billion.

In total, five transactions during 2024 had a value exceeding $5 billion each, compared to two high value deals in 2023 and one in 2022. During 2024, the two largest value deals were in the biopharmaceutical sector; they involved Sanofi ($17.3 billion) and Catalent ($16.5 billion). The companies involved in the remaining high . . .